Coronary artery bypass grafting surgery without the routine application of blood products:: is it feasible?

被引:23
作者
Wilhelmi, M [1 ]
Franke, U
Cohnert, T
Weber, P
Kaukemüller, J
Fischer, S
Wahlers, T
Haverich, A
机构
[1] Hannover Med Sch, Dept Thorac & Cardiovasc Surg, D-3000 Hannover, Germany
[2] Univ Hosp Jena, Dept Cardiovasc Surg, Jena, Germany
[3] Hannover Med Sch, Dept Anaesthesiol OSK 4, D-3000 Hannover, Germany
关键词
blood products; coronary artery bypass grafting; transfusion;
D O I
10.1016/S1010-7940(01)00648-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Fresh frozen plasma (FFP) substitution is currently standard practise in cardiac surgery. In this study we investigate whether elective coronary artery bypass grafting (CABG) surgery is feasible without the administration of blood products compared to the substitution of fresh frozen plasma. Patients and methods: From September 1997 to April 1998, 120 consecutive patients underwent CABG surgery at our institution. In the FFP group patients (n = 60; men, n = 43; women, n = 17; mean age: 64 +/- 8.5 years) received 4 units of fresh frozen plasma (FFP) intraoperatively. In comparison, patients in the control group (n = 60; men, n = 44; women, n = 16; mean age: 65 +/- 7.5 years) did not receive FFP. Main endpoints included perioperative hematologic parameters, blood loss, and the amount of blood products that were administered. Results: Intraoperatively, the substitution of packed red blood cells (pRBC) in the FFP group was significantly higher compared with the control group (0.63 +/- 0.94 units/patient vs. 0.12 +/- 0.38 units/patient, P = 0.001). Postoperatively, patients in the FFP group required significantly more pRBC products than patients in the control group (0.78 +/- 1.09 vs. 0.42 +/- 0.77, P = 0.024). There were no significant differences in hemoglobin (FFP group: 99 +/- 11.1 g/dl; control group: 105 +/- 13.5 g/dl) and hematocrit levels (FFP group: 30 +/- 3.39%; control group: 32 +/- 4%). Also, no significant differences regarding the postoperative blood loss was observed between groups (FFP group: 588 +/- 224 vs. control group: 576 +/- 272 ml/24 h). Conclusions: This study clearly demonstrates that the avoidance of routine intraoperative FFP administration does not lead to an increase in blood loss postoperatively compared to patients that received FFPs. Furthermore, we did not observe increased requirements for postoperative FFP infusion in patients that did not receive FFPs intraoperatively. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:657 / 661
页数:5
相关论文
共 19 条
[1]   Viruses and prions: update on blood safety [J].
Barin, F .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2000, 7 :5S-10S
[2]  
BARNETTE RE, 1988, ANESTH ANALG, V67, P57
[3]  
BOLDT J, 1989, ANAESTHESIST, V38, P353
[4]  
BREYER RH, 1987, J THORAC CARDIOV SUR, V93, P512
[5]  
CAMPBELL FW, 1993, PLATELET FUNCTION CA, P407
[6]   The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified [J].
Consten, ECJ ;
Henny, CP ;
Eijsman, L ;
Dongelmans, DA ;
vanOers, MHJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (01) :162-167
[7]   Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation [J].
Grossmann, R ;
Ebell, JB ;
Misoph, M ;
Schwender, S ;
Neukam, K ;
Hickethier, T ;
Elert, O ;
Keller, F .
HEART AND VESSELS, 1996, 11 (06) :310-317
[8]   BLEEDING AFTER CARDIOPULMONARY BYPASS [J].
HARKER, LA .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (22) :1446-1448
[9]  
HOGMANN CF, 1988, ACTA ANAESTH SCAND, V32, P558
[10]   Shed mediastinal blood transfusion after cardiac operations: A cost-effectiveness analysis [J].
Kilgore, ML ;
Pacifico, AD .
ANNALS OF THORACIC SURGERY, 1998, 65 (05) :1248-1254